Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$1.92 USD
-0.03 (-1.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.92 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value B Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: AMC |
3/2024 | $-3.65 | 0.00% |
Earnings Summary
For their last quarter, Emergent Biosolutions (EBS) reported earnings of -$0.77 per share, missing the Zacks Consensus Estimate of -$0.33 per share. This reflects a negative earnings surprise of 133.33%. Look out for EBS's next earnings release on May 01, 2024. For the next earning release, we expect the company to report earnings of -$3.65 per share, reflecting a year-over-year decrease of 15.14%.
Earnings History
Price & Consensus
Zacks News for EBS
Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates
EBS: What are Zacks experts saying now?
Zacks Private Portfolio Services